Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Publication Title,Pubmed Url,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId,Dataset View_id
PublicationView,CA231978,10.3390/cancers15092552,Cancers (Basel),37174018,Management of Advanced Prostate Cancer in the Precision Oncology Era,https://pubmed.ncbi.nlm.nih.gov/37174018,2023,"Immunotherapy, Chemotherapy, Biomarkers, Theranostics, Advanced Prostate Cancer, Genomic Selection, Parp Inhibitors, Metastatic Prostate Cancer, Psma, Radioligand Therapy","Claire M Gillette, Gabriel A Yette, Scott D Cramer, Laura S Graham","Prostate cancer (PC) is the second leading cause of cancer death in men in the United States. While diversified and improved treatment options for aggressive PC have improved patient outcomes, metastatic castration-resistant prostate cancer (mCRPC) remains incurable and an area of investigative therapeutic interest. This review will cover the seminal clinical data supporting the indication of new (Read more on Pubmed)",Immunotherapy,Prostate Adenocarcinoma,Prostate Gland,Not Applicable,Open Access,37174018,bf2df3cb-429f-4136-a0f6-28f1d12d4680,syn52565112,37174018
PublicationView,CA231978,10.1038/s41597-023-02335-4,Sci Data,37407670,"A harmonized resource of integrated prostate cancer clinical, -omic, and signature features",https://pubmed.ncbi.nlm.nih.gov/37407670,2023,,"Teemu D Laajala, Varsha Sreekanth, Alex C Soupir, Jordan H Creed, Anni S Halkola, Federico C F Calboli, Kalaimathy Singaravelu, Michael V Orman, Christelle Colin-Leitzinger, Travis Gerke, Brooke L Fridley, Svitlana Tyekucheva, James C Costello","Genomic and transcriptomic data have been generated across a wide range of prostate cancer (PCa) study cohorts. These data can be used to better characterize the molecular features associated with clinical outcomes and to test hypotheses across multiple, independent patient cohorts. In addition, derived features, such as estimates of cell composition, risk scores, and androgen receptor (AR) scores(Read more on Pubmed)",Computational Tool,Pan-cancer,Not Applicable,"GSE18655, GSE691955, GSE134051, GSE54691, GSE210945, GSE11961650, GSE1420689, GSE2513652",Open Access,37407670,6c4d4644-aead-4898-bb03-3ecf7f019122,syn52565112,37407670
